cris.boxmetadata.label.title
Securinine derivatives as potential anti-amyloid therapeutic approach
cris.boxmetadata.label.dateissued
01 browse.startsWith.months.january 2017
cris.boxmetadata.label.accesslevel
metadata only access
cris.boxmetadata.label.resourcetype
research article
cris.boxmetadata.label.authors
Neganova M.E.
Klochkov S.G.
Petrova L.N.
Shevtsova E.F.
Afanasieva S.V.
Chudinova E.S.
Fisenko V.P.
Bachurin S.O.
Aliev G.
Pontificia Universidad Javeriana
cris.boxmetadata.label.abstract
Background: Oxidative stress and amyloid deposition are tightly interconnected pathological features of Alzheimer disease. In this respect, both amyloid production and aggregation may be stimulated by oxidative stress and also the increase of pathogenic β-amyloid and its aggregated form lead to oxidative stress progression. Therefore, the search for potential drugs with both antioxidant and antiaggregation properties are of great interest. Methods: In this study, we described the stereospecific synthesis of alkaloid securinine aminoderivatives. Results: We showed that the newly synthesized compounds possess antioxidant and metal-chelating properties. Indeed, we report that one compound has inhibitory effects towards β-amyloid aggregation. Conclusion: Based on these results, aminoderivatives of securinine scaffold are promising compounds for development of new drugs for the treatment of neurodegenerative diseases.
cris.boxmetadata.label.citationstartpage
351
cris.boxmetadata.label.citationendpage
355
cris.boxmetadata.label.volume
16
cris.boxmetadata.label.issue
3
cris.boxmetadata.label.language
English
cris.boxmetadata.label.ocdeknowledgeArea
Neurociencias
cris.boxmetadata.label.doi
cris.boxmetadata.label.scopusidentifier
2-s2.0-85038264361
cris.boxmetadata.label.pubmedidentifier
cris.boxmetadata.label.source
CNS and Neurological Disorders - Drug Targets
cris.boxmetadata.label.containerissn
18715273
cris.boxmetadata.label.sponsor
This work supported by the Russian Scientific Foundation (www.rscf.ru, Grant No. 14-23-00160 for 2014-2016: Directed design, synthesis, and study of biological activity of multi-target compounds as innovative drugs for treatment of neurodegenerative diseases).
peru-layout.shadow-copies Directorio de Producción Científica Scopus